DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Moreno-Pérez O, Andres M, Leon-Ramirez JM. et al.
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of
follow-up: A retrospective cohort study.
J Autoimmun 2020;
114: 102523
DOI: 10.1016/j.jaut.2020.102523.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.